# The Effect of Buprenorphine Continuation for Patients With Opioid Use Disorder

> **NCT04981678** · PHASE4 · TERMINATED · sponsor: **MaineHealth** · enrollment: 12 (actual)

## Conditions studied

- Opioid-use Disorder

## Interventions

- **DRUG:** Buprenorphine
- **DRUG:** Buprenorphine

## Key facts

- **NCT ID:** NCT04981678
- **Lead sponsor:** MaineHealth
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-01-01
- **Primary completion:** 2023-09-15
- **Final completion:** 2023-10-16
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** This study was halted prior to accumulating the full number of participants due to difficulty in recruiting study subjects.
- **Last updated:** 2024-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04981678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04981678, "The Effect of Buprenorphine Continuation for Patients With Opioid Use Disorder". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04981678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*